Please try another search
For the fiscal year ended 31 December 2021, Bio-Gate AG revenues increased 21% to EUR6.2M. Net loss decreased 32% to EUR544K. Revenues reflect Cosmetic Products segment increase of 23% to EUR3.7M, Silver & Polymers segment increase from EUR191K to EUR429K, Germany segment increase of 17% to EUR4.4M, EU without Germany segment increase of 83% to EUR969K. Lower net loss reflects Amortization of Goodwill decrease from EUR111K (expense) to EUR0K.
Period Ending: | Dec 31, 2021 | Jun 30, 2021 | Dec 31, 2020 | Jun 30, 2020 |
---|---|---|---|---|
Total Revenue | 3.12 | 3.11 | 2.7 | 2.43 |
Gross Profit | 1.89 | 1.94 | 1.62 | 1.45 |
Operating Income | -0.47 | -0.07 | -0.53 | -0.29 |
Net Income | -0.45 | -0.09 | -0.48 | -0.32 |
Period Ending: | Dec 31, 2021 | Jun 30, 2021 | Dec 31, 2020 | Jun 30, 2020 |
---|---|---|---|---|
Total Assets | 5.21 | 5.38 | 3.31 | 3.75 |
Total Liabilities | 1.55 | 1.24 | 1.75 | 1.87 |
Total Equity | 3.67 | 4.14 | 1.56 | 1.88 |
Period Ending: | Dec 31, 2021 | Jun 30, 2021 | Dec 31, 2020 | Jun 30, 2020 |
---|---|---|---|---|
Period Length: | 12 Months | 6 Months | 12 Months | 6 Months |
Cash From Operating Activities | -0.63 | -0.95 | -0.6 | -0.23 |
Cash From Investing Activities | -0.54 | -0.23 | -0.11 | -0.05 |
Cash From Financing Activities | 2.72 | 2.63 | 0.66 | 0.47 |
Net Change in Cash | 1.55 | 1.44 | -0.04 | 0.19 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review